Month: September 2025

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine) extended-release tablets Patients reported high satisfaction (>89%) with AUSTEDO XR, with 96% expressing interest in continuing treatment Almost all (>96%) patients relayed that AUSTEDO XR was easy to takePARSIPPANY, N.J. and TEL AVIV, Israel, Sept. 20, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of data from a real-world survey of patients taking AUSTEDO XR® (deutetrabenazine) extended-release tablets. Patients taking AUSTEDO XR reported increased social and emotional well-being as a result of movement reduction, and high overall satisfaction with AUSTEDO XR. The...

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with olanzapine LAI (TEV-‘749) and its long-term systemic safety profile was consistent with other olanzapine formulations1 Additional new data comparing initiation of UZEDY® (risperidone) versus Invega Sustenna® (paliperidone palmitate) in hospitalized patients found that UZEDY was associated with shorter length of stay and was preferred overall by HCPs due to its dosing characteristics and ease of use1 Teva is committed to researching and developing innovative medicines that help address unmet needs for individuals living with complex mental health conditionsPARSIPPANY, N.J., and TEL AVIV, Israel, Sept. 20, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical...

Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response Rate (ORR) at the Highest Dose Level (100 µg) and a 40% ORR at the 75 µg Dose Level in a Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma Patient Population Responses Across Dose Levels With Median Duration of Response of 9.3 Months as of the Data Cut-off Date; Median Duration of Response Not Yet Reached at Two Highest Doses No Discontinuations Related to Cemsidomide and Few Dose Reductions Support a Safety Profile That May Be Ideal for Combination Regimens C4T to Pursue Differentiated Development Strategy With Two Distinct Opportunities for Accelerated Approval in Second Line and Later C4T to Host Webcast Today at 3 pm ET; Webcast Link Available Here WATERTOWN, Mass., Sept. 20, 2025 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC),...

MT Højgaard Holding’s business MT Højgaard Danmark has won Metroselskabet’s tender for the planning, development and construction of two new metro stations on the M4 line in the outer part of Nordhavn in Copenhagen. The project is tendered with early contractor involvement. MT Højgaard Danmark has been selected as turnkey contractor and will collaborate with Rambøll and Cobe for the development, design and construction of the project. After the standstill period expires on 29 September 2025, a contract will be entered into for a collaboration phase, where the project will be developed and designed in close collaboration with Metroselskabet. After the collaboration phase, it is the intention to enter a design and construction contract with a total estimated contract sum of DKK 900 million. Construction is expected to begin in 2027 with...

OTTAWA, Ill., Sept. 19, 2025 (GLOBE NEWSWIRE) — Ottawa Bancorp, Inc. (OTCQX: OTTW), the “Company”, the holding company for OSB Community Bank, announced today that the Company has completed its previously announced stock repurchase program. Under the program, the Company repurchased 120,996 shares of its outstanding common stock at an average price of $15.01 per share. Ottawa Bancorp, Inc. is the holding company for OSB Community Bank which provides various financial services to individual and corporate customers in the United States. OSB Community Bank offers various deposit accounts, including checking, money market, regular savings, club savings, certificate, and various retirement accounts. Its loan portfolio includes one-to-four family residential mortgage, multi-family and non-residential real estate, commercial, and construction...

– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES – Vancouver, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) — First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCPK: FAUMF) (the “Company”) is pleased to announce, further to its news releases of August 14 and 29, 2025,  that the Company has closed the second tranche of the previously announced non-brokered private placement (the “Offering”) of common shares in the capital of the Company (the “Shares”) by the issuance of 1,611,000 Shares at $0.30 per Share for gross proceeds of $483,300.00 (the “Second Tranche”).  The Company expects to close a third and final tranche of the Offering on or before October 1, 2025. In connection with the Second Tranche, the Company paid finder’s fees to eligible finders consisting of $13,020.00 in cash...

LOS ANGELES and CARLSBAD, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) — Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, and Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“QLGN”), jointly announced that they have entered into a securities purchase agreement (the “Agreement”) for a private investment in public equity (PIPE) in QLGN’s common stock and preferred stock, and will start a crypto and web3-related business. Upon completion of the required stockholder approval process, it is expected that QLGN will rebrand as CXC10, fully focusing on its three growth engines in crypto and ecosystem buildup for Web3. The PIPE financing is being led by Faraday Future and its Founder and Global Co-CEO YT Jia,...

New York, Sept. 19, 2025 (GLOBE NEWSWIRE) — CEA Industries Inc. (Nasdaq: BNC), (“BNC” or the “Company”), the world’s leading corporate holder of BNB and prominent industry advocate of BNB adoption, today announced that its Board of Directors has authorized a stock repurchase program of up to $250 million of the Company’s common stock. David Namdar, CEO of CEA Industries (BNC): “This buyback program reflects our confidence in the long-term value of CEA Industries and our conviction in BNB, which is trading near all time highs. We intend to act opportunistically when our shares trade below intrinsic value, with the goal of enhancing net asset value per share and delivering sustained returns for our shareholders. With the world’s leading BNB digital asset treasury as our foundation, by repurchasing at a discount, we not only...

LOS ANGELES and CARLSBAD, Sept. 19, 2025 (GLOBE NEWSWIRE) — Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, and Qualigen Therapeutics, Inc. (NASDAQ:QLGN) (“QLGN”), jointly announced that they have entered into a securities purchase agreement (the “Agreement”) for a private investment in public equity (PIPE) in QLGN’s common stock and preferred stock, and will start a in Crypto and web3-related business. The PIPE financing is being led by Faraday Future and its Founder and Global Co-CEO YT Jia, together with other investors including SIGN Foundation, a blockchain technology company backed by Binance Labs, Sequoia Capital (US, India, China), IDG, and Circle, building software infrastructure...

LONDON, Sept. 19, 2025 (GLOBE NEWSWIRE) — RedCloud Holdings plc (Nasdaq: RCT) (“RedCloud” or the “Company”) the technology company behind the RedAI trading platform used by Fast Moving Consumer Goods (FMCG) Manufacturers, Distributors and Retailers, today announced that Justin Floyd, CEO and Co-Founder will be speaking at the 3rd Annual Roth AI Summit 2025 on September 24. The Company will outline it’s AI-fueled mission to transform the $14.6Tn2 Global FMCG market, which—through a combination of complexity, outdated systems and offline trading—battles with an estimated $2Tn1 global ‘Inventory Gap’ that prevents products reaching consumers. This gap translates to lost opportunity on an epic scale for supply chain businesses—and ultimately impacts consumers of everyday goods across the world.   The Company has made a number of recent...